It's All About The Company You Keep

 

Catalyst Pharmaceuticals is committed to improving the lives of people with rare diseases

 

 

 

Make A World Of Difference

2018 AAN Annual Meeting, Advancing Neurology, Advancing You, Los Angeles, CA April 21-27, 2018

Leading the Way

 

Researching an investigational treatment for Lambert-Eaton myasthenic syndrome (LEMS)

 

 

 

It's All About The Company You Keep

 

 

Catalyst Pharmaceuticals is committed to improving the lives of people with rare diseases

Make A World Of Difference

 

2018 AAN Annual Meeting, Advancing Neurology, Advancing You, Los Angeles, CA April 21-27, 2018

Leading the Way

Researching an investigational treatment for Lambert-Eaton myasthenic syndrome (LEMS)

 

 

 

At Catalyst Pharmaceuticals, we understand that receiving a rare disease diagnosis can be extremely difficult. Often patients feel isolated and hopeless. That’s why we believe that, when you’re battling a rare disease—it’s all about the company you keep.

Our company is committed to developing novel, safe, and efficacious therapies that will improve the lives of people with rare and ultra-rare diseases.

Corporate Citizenship

 Social responsibility is at the heart of everything we do

 

 

/responsibility/

A Singular Mission

To improve the lives of patients with rare and ultra-rare diseases

 

/about-catalyst/

Partnering With Patients

Empowering patients to take an active role in their health care

 

/patient-first/

Cutting-Edge Science

The innovation behind a breakthrough

 

 

/research-pipeline/

News & Events